InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (12 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
12
T+90 hit rate
57%
T+90 mean return
+1.2%
Across 7 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by ROBERTS EIRY, Directeur Médical. Officer active across 3 companies, notably Amicus Therapeutics, INC.. In total, 25 disclosures have been published. Breakdown: 0 buy · 12 sells. Total volume traded: €4.1m. History available since 10 June 2021. The latest transaction was filed on 22 May 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations25 total
45,871 shares0Common Shares, No Par ValueSEC:0000885590-26-000082:0
2,113 shares0Common StockSEC:0000914475-25-000069:0
1,860 shares0Common StockSEC:0000914475-25-000051:0
2,769 shares0Common StockSEC:0000914475-25-000029:0
5,140 shares@ US$77.814.4% of flowCommon StockSEC:0000914475-24-000220:0
11,847 shares0Common StockSEC:0000950170-24-071007:0
1,114 shares@ US$132.96391.6% of flowCommon StockSEC:0000914475-24-000076:0
1,121 shares@ US$142.23561.8% of flowCommon StockSEC:0000914475-24-000049:0
1,457 shares@ US$140.79062.2% of flowCommon StockSEC:0000914475-24-000031:0
10,000 shares@ US$126.744813.7% of flowCommon StockSEC:0001209191-23-059774:0
6,978 shares@ US$81.056.2% of flowCommon StockSEC:0001209191-23-058683:0
38,722 shares@ US$77.8133.2% of flowCommon StockSEC:0001209191-23-058116:0
8,396 shares@ US$77.817.2% of flowCommon StockSEC:0001209191-23-057986:0
3,198 shares@ US$107.37583.7% of flowCommon StockSEC:0001209191-23-047140:0
8,584 shares0Common StockSEC:0001209191-23-036422:0
14,400 shares@ US$103.476316.0% of flowCommon StockSEC:0001209191-23-025763:0
1,121 shares@ US$105.80041.3% of flowCommon StockSEC:0001209191-23-007916:0
1,457 shares@ US$109.98871.8% of flowCommon StockSEC:0001209191-23-006282:0
12,671 shares0Common StockSEC:0001209191-22-035847:0
1,623 shares@ US$80.76760.0008% mcap19.9% of flowCommon StockSEC:0001209191-22-008216:0
1,623 shares@ US$80.76761.4% of flowCommon StockSEC:0001209191-22-008216
2,632 shares@ US$74.50140.0012% mcap30.1% of flowCommon StockSEC:0001209191-22-003104:0
2,632 shares@ US$74.50142.1% of flowCommon StockSEC:0001209191-22-003104
22,759 shares0Common StockSEC:0001209191-21-040374
22,759 shares0Common StockSEC:0001209191-21-040374:0
25 of 25 declarations
About ROBERTS EIRY
Eiry Roberts is the Chief Medical Officer at AMICUS THERAPEUTICS, INC. and NEUROCRINE BIOSCIENCES INC. He is responsible for leading the medical and clinical initiatives of these companies. His expertise in the life sciences field is essential for developing innovative treatments.
